The monkey pox vaccine is currently in Phase 2 clinical trials. While there are no definitive timelines, it is estimated that the vaccine may be available as early as 202
There is a lot of research still in progress, with the vaccine initially being tested primarily in healthy adults. Animal studies have already demonstrated promising results, and once approved, the vaccine will be further tested in a larger clinical trial in healthy adults and in children.